Global and China Vaccines & Vaccination Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 22-Sep-2021
No. of pages: 107
Inquire Before Buying

Global Vaccines & Vaccination Scope and Market Size

Vaccines & Vaccination market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vaccines & Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Subunit vaccines

- Live attenuated vaccines

- Conjugate vaccines

- Inactivated vaccines

- Recombinant vector vaccines

- Toxoid vaccines

- Synthetic vaccines

- Dendritic cell vaccines

Segment by Application

- Baby Vaccine

- Adult Special Vaccine

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Abbott

- AstraZeneca

- Bavarian Nordic

- Novartis

- Bharat Biotech

- Bio-Med

- CSL

- Emergent BioSolutions

- GSK

- Johnson & Johnson

- Pfizer

- Merck

- Sanofi

Global and China Vaccines & Vaccination Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vaccines & Vaccination Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Subunit vaccines
1.2.3 Live attenuated vaccines
1.2.4 Conjugate vaccines
1.2.5 Inactivated vaccines
1.2.6 Recombinant vector vaccines
1.2.7 Toxoid vaccines
1.2.8 Synthetic vaccines
1.2.9 Dendritic cell vaccines
1.3 Market by Application
1.3.1 Global Vaccines & Vaccination Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Baby Vaccine
1.3.3 Adult Special Vaccine
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vaccines & Vaccination Market Perspective (2016-2027)
2.2 Vaccines & Vaccination Growth Trends by Regions
2.2.1 Vaccines & Vaccination Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vaccines & Vaccination Historic Market Share by Regions (2016-2021)
2.2.3 Vaccines & Vaccination Forecasted Market Size by Regions (2022-2027)
2.3 Vaccines & Vaccination Industry Dynamic
2.3.1 Vaccines & Vaccination Market Trends
2.3.2 Vaccines & Vaccination Market Drivers
2.3.3 Vaccines & Vaccination Market Challenges
2.3.4 Vaccines & Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vaccines & Vaccination Players by Revenue
3.1.1 Global Top Vaccines & Vaccination Players by Revenue (2016-2021)
3.1.2 Global Vaccines & Vaccination Revenue Market Share by Players (2016-2021)
3.2 Global Vaccines & Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vaccines & Vaccination Revenue
3.4 Global Vaccines & Vaccination Market Concentration Ratio
3.4.1 Global Vaccines & Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vaccines & Vaccination Revenue in 2020
3.5 Vaccines & Vaccination Key Players Head office and Area Served
3.6 Key Players Vaccines & Vaccination Product Solution and Service
3.7 Date of Enter into Vaccines & Vaccination Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vaccines & Vaccination Breakdown Data by Type
4.1 Global Vaccines & Vaccination Historic Market Size by Type (2016-2021)
4.2 Global Vaccines & Vaccination Forecasted Market Size by Type (2022-2027)
5 Vaccines & Vaccination Breakdown Data by Application
5.1 Global Vaccines & Vaccination Historic Market Size by Application (2016-2021)
5.2 Global Vaccines & Vaccination Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Vaccines & Vaccination Market Size (2016-2027)
6.2 North America Vaccines & Vaccination Market Size by Type
6.2.1 North America Vaccines & Vaccination Market Size by Type (2016-2021)
6.2.2 North America Vaccines & Vaccination Market Size by Type (2022-2027)
6.2.3 North America Vaccines & Vaccination Market Size by Type (2016-2027)
6.3 North America Vaccines & Vaccination Market Size by Application
6.3.1 North America Vaccines & Vaccination Market Size by Application (2016-2021)
6.3.2 North America Vaccines & Vaccination Market Size by Application (2022-2027)
6.3.3 North America Vaccines & Vaccination Market Size by Application (2016-2027)
6.4 North America Vaccines & Vaccination Market Size by Country
6.4.1 North America Vaccines & Vaccination Market Size by Country (2016-2021)
6.4.2 North America Vaccines & Vaccination Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Vaccines & Vaccination Market Size (2016-2027)
7.2 Europe Vaccines & Vaccination Market Size by Type
7.2.1 Europe Vaccines & Vaccination Market Size by Type (2016-2021)
7.2.2 Europe Vaccines & Vaccination Market Size by Type (2022-2027)
7.2.3 Europe Vaccines & Vaccination Market Size by Type (2016-2027)
7.3 Europe Vaccines & Vaccination Market Size by Application
7.3.1 Europe Vaccines & Vaccination Market Size by Application (2016-2021)
7.3.2 Europe Vaccines & Vaccination Market Size by Application (2022-2027)
7.3.3 Europe Vaccines & Vaccination Market Size by Application (2016-2027)
7.4 Europe Vaccines & Vaccination Market Size by Country
7.4.1 Europe Vaccines & Vaccination Market Size by Country (2016-2021)
7.4.2 Europe Vaccines & Vaccination Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Vaccines & Vaccination Market Size (2016-2027)
8.2 Asia-Pacific Vaccines & Vaccination Market Size by Type
8.2.1 Asia-Pacific Vaccines & Vaccination Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vaccines & Vaccination Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vaccines & Vaccination Market Size by Type (2016-2027)
8.3 Asia-Pacific Vaccines & Vaccination Market Size by Application
8.3.1 Asia-Pacific Vaccines & Vaccination Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vaccines & Vaccination Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vaccines & Vaccination Market Size by Application (2016-2027)
8.4 Asia-Pacific Vaccines & Vaccination Market Size by Region
8.4.1 Asia-Pacific Vaccines & Vaccination Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vaccines & Vaccination Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vaccines & Vaccination Market Size (2016-2027)
9.2 Latin America Vaccines & Vaccination Market Size by Type
9.2.1 Latin America Vaccines & Vaccination Market Size by Type (2016-2021)
9.2.2 Latin America Vaccines & Vaccination Market Size by Type (2022-2027)
9.2.3 Latin America Vaccines & Vaccination Market Size by Type (2016-2027)
9.3 Latin America Vaccines & Vaccination Market Size by Application
9.3.1 Latin America Vaccines & Vaccination Market Size by Application (2016-2021)
9.3.2 Latin America Vaccines & Vaccination Market Size by Application (2022-2027)
9.3.3 Latin America Vaccines & Vaccination Market Size by Application (2016-2027)
9.4 Latin America Vaccines & Vaccination Market Size by Country
9.4.1 Latin America Vaccines & Vaccination Market Size by Country (2016-2021)
9.4.2 Latin America Vaccines & Vaccination Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vaccines & Vaccination Market Size (2016-2027)
10.2 Middle East & Africa Vaccines & Vaccination Market Size by Type
10.2.1 Middle East & Africa Vaccines & Vaccination Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vaccines & Vaccination Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vaccines & Vaccination Market Size by Type (2016-2027)
10.3 Middle East & Africa Vaccines & Vaccination Market Size by Application
10.3.1 Middle East & Africa Vaccines & Vaccination Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vaccines & Vaccination Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vaccines & Vaccination Market Size by Application (2016-2027)
10.4 Middle East & Africa Vaccines & Vaccination Market Size by Country
10.4.1 Middle East & Africa Vaccines & Vaccination Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vaccines & Vaccination Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Vaccines & Vaccination Introduction
11.1.4 Abbott Revenue in Vaccines & Vaccination Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Vaccines & Vaccination Introduction
11.2.4 AstraZeneca Revenue in Vaccines & Vaccination Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Bavarian Nordic
11.3.1 Bavarian Nordic Company Details
11.3.2 Bavarian Nordic Business Overview
11.3.3 Bavarian Nordic Vaccines & Vaccination Introduction
11.3.4 Bavarian Nordic Revenue in Vaccines & Vaccination Business (2016-2021)
11.3.5 Bavarian Nordic Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Vaccines & Vaccination Introduction
11.4.4 Novartis Revenue in Vaccines & Vaccination Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Bharat Biotech
11.5.1 Bharat Biotech Company Details
11.5.2 Bharat Biotech Business Overview
11.5.3 Bharat Biotech Vaccines & Vaccination Introduction
11.5.4 Bharat Biotech Revenue in Vaccines & Vaccination Business (2016-2021)
11.5.5 Bharat Biotech Recent Development
11.6 Bio-Med
11.6.1 Bio-Med Company Details
11.6.2 Bio-Med Business Overview
11.6.3 Bio-Med Vaccines & Vaccination Introduction
11.6.4 Bio-Med Revenue in Vaccines & Vaccination Business (2016-2021)
11.6.5 Bio-Med Recent Development
11.7 CSL
11.7.1 CSL Company Details
11.7.2 CSL Business Overview
11.7.3 CSL Vaccines & Vaccination Introduction
11.7.4 CSL Revenue in Vaccines & Vaccination Business (2016-2021)
11.7.5 CSL Recent Development
11.8 Emergent BioSolutions
11.8.1 Emergent BioSolutions Company Details
11.8.2 Emergent BioSolutions Business Overview
11.8.3 Emergent BioSolutions Vaccines & Vaccination Introduction
11.8.4 Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2016-2021)
11.8.5 Emergent BioSolutions Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Vaccines & Vaccination Introduction
11.9.4 GSK Revenue in Vaccines & Vaccination Business (2016-2021)
11.9.5 GSK Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Vaccines & Vaccination Introduction
11.10.4 Johnson & Johnson Revenue in Vaccines & Vaccination Business (2016-2021)
11.10.5 Johnson & Johnson Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Vaccines & Vaccination Introduction
11.11.4 Pfizer Revenue in Vaccines & Vaccination Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Merck
11.12.1 Merck Company Details
11.12.2 Merck Business Overview
11.12.3 Merck Vaccines & Vaccination Introduction
11.12.4 Merck Revenue in Vaccines & Vaccination Business (2016-2021)
11.12.5 Merck Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Vaccines & Vaccination Introduction
11.13.4 Sanofi Revenue in Vaccines & Vaccination Business (2016-2021)
11.13.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Subunit vaccines
Table 3. Key Players of Live attenuated vaccines
Table 4. Key Players of Conjugate vaccines
Table 5. Key Players of Inactivated vaccines
Table 6. Key Players of Recombinant vector vaccines
Table 7. Key Players of Toxoid vaccines
Table 8. Key Players of Synthetic vaccines
Table 9. Key Players of Dendritic cell vaccines
Table 10. Global Vaccines & Vaccination Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Vaccines & Vaccination Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Vaccines & Vaccination Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Vaccines & Vaccination Market Share by Regions (2016-2021)
Table 14. Global Vaccines & Vaccination Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Vaccines & Vaccination Market Share by Regions (2022-2027)
Table 16. Vaccines & Vaccination Market Trends
Table 17. Vaccines & Vaccination Market Drivers
Table 18. Vaccines & Vaccination Market Challenges
Table 19. Vaccines & Vaccination Market Restraints
Table 20. Global Vaccines & Vaccination Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Vaccines & Vaccination Market Share by Players (2016-2021)
Table 22. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines & Vaccination as of 2020)
Table 23. Ranking of Global Top Vaccines & Vaccination Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Vaccines & Vaccination Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Vaccines & Vaccination Product Solution and Service
Table 27. Date of Enter into Vaccines & Vaccination Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Vaccines & Vaccination Revenue Market Share by Type (2016-2021)
Table 31. Global Vaccines & Vaccination Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Vaccines & Vaccination Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Vaccines & Vaccination Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Vaccines & Vaccination Revenue Market Share by Application (2016-2021)
Table 35. Global Vaccines & Vaccination Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Vaccines & Vaccination Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Vaccines & Vaccination Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Vaccines & Vaccination Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Vaccines & Vaccination Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Vaccines & Vaccination Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Vaccines & Vaccination Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Vaccines & Vaccination Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Vaccines & Vaccination Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Vaccines & Vaccination Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Vaccines & Vaccination Product
Table 70. Abbott Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. AstraZeneca Company Details
Table 73. AstraZeneca Business Overview
Table 74. AstraZeneca Vaccines & Vaccination Product
Table 75. AstraZeneca Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 76. AstraZeneca Recent Development
Table 77. Bavarian Nordic Company Details
Table 78. Bavarian Nordic Business Overview
Table 79. Bavarian Nordic Vaccines & Vaccination Product
Table 80. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 81. Bavarian Nordic Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Vaccines & Vaccination Product
Table 85. Novartis Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Bharat Biotech Company Details
Table 88. Bharat Biotech Business Overview
Table 89. Bharat Biotech Vaccines & Vaccination Product
Table 90. Bharat Biotech Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 91. Bharat Biotech Recent Development
Table 92. Bio-Med Company Details
Table 93. Bio-Med Business Overview
Table 94. Bio-Med Vaccines & Vaccination Product
Table 95. Bio-Med Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 96. Bio-Med Recent Development
Table 97. CSL Company Details
Table 98. CSL Business Overview
Table 99. CSL Vaccines & Vaccination Product
Table 100. CSL Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 101. CSL Recent Development
Table 102. Emergent BioSolutions Company Details
Table 103. Emergent BioSolutions Business Overview
Table 104. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 105. Emergent BioSolutions Recent Development
Table 106. GSK Company Details
Table 107. GSK Business Overview
Table 108. GSK Vaccines & Vaccination Product
Table 109. GSK Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 110. GSK Recent Development
Table 111. Johnson & Johnson Company Details
Table 112. Johnson & Johnson Business Overview
Table 113. Johnson & Johnson Vaccines & Vaccination Product
Table 114. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 115. Johnson & Johnson Recent Development
Table 116. Pfizer Company Details
Table 117. Pfizer Business Overview
Table 118. Pfizer Vaccines & Vaccination Product
Table 119. Pfizer Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 120. Pfizer Recent Development
Table 121. Merck Company Details
Table 122. Merck Business Overview
Table 123. Merck Vaccines & Vaccination Product
Table 124. Merck Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 125. Merck Recent Development
Table 126. Sanofi Company Details
Table 127. Sanofi Business Overview
Table 128. Sanofi Vaccines & Vaccination Product
Table 129. Sanofi Revenue in Vaccines & Vaccination Business (2016-2021) & (US$ Million)
Table 130. Sanofi Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vaccines & Vaccination Market Share by Type: 2020 VS 2027
Figure 2. Subunit vaccines Features
Figure 3. Live attenuated vaccines Features
Figure 4. Conjugate vaccines Features
Figure 5. Inactivated vaccines Features
Figure 6. Recombinant vector vaccines Features
Figure 7. Toxoid vaccines Features
Figure 8. Synthetic vaccines Features
Figure 9. Dendritic cell vaccines Features
Figure 10. Global Vaccines & Vaccination Market Share by Application: 2020 VS 2027
Figure 11. Baby Vaccine Case Studies
Figure 12. Adult Special Vaccine Case Studies
Figure 13. Other Case Studies
Figure 14. Vaccines & Vaccination Report Years Considered
Figure 15. Global Vaccines & Vaccination Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Vaccines & Vaccination Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Vaccines & Vaccination Market Share by Regions: 2020 VS 2027
Figure 18. Global Vaccines & Vaccination Market Share by Regions (2022-2027)
Figure 19. Global Vaccines & Vaccination Market Share by Players in 2020
Figure 20. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vaccines & Vaccination as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2020
Figure 22. Global Vaccines & Vaccination Revenue Market Share by Type (2016-2021)
Figure 23. Global Vaccines & Vaccination Revenue Market Share by Type (2022-2027)
Figure 24. North America Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 26. North America Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 27. North America Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 28. United States Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 32. Europe Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 33. Europe Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 34. Germany Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Vaccines & Vaccination Market Share by Region (2016-2027)
Figure 44. China Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 52. Latin America Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 53. Latin America Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 54. Mexico Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Vaccines & Vaccination Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Vaccines & Vaccination Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Vaccines & Vaccination Market Share by Country (2016-2027)
Figure 60. Turkey Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Vaccines & Vaccination Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Abbott Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 64. AstraZeneca Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 65. Bavarian Nordic Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 67. Bharat Biotech Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 68. Bio-Med Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 69. CSL Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 70. Emergent BioSolutions Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 71. GSK Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 73. Pfizer Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 75. Sanofi Revenue Growth Rate in Vaccines & Vaccination Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs